Statistics for MoonLake Immunotherapeutics (id:5274 MLTX)
Valuation metrics
Market cap
3.31B
Enterprise value
2.60B
Trailing P/E (ttm)
-68.25
Forward P/E
-19.45
PEG ratio
-19.45
Price/Sales (ttm)
Price/Book (mrq)
6.31
Enterprise Value/Revenue
Enterprise Value/EBITDA
-23.94
Overview
Shares outstanding
63.06M
Float
25.99M
Shares short
8.06M
% Held by insiders
0.15%
% Held by institutions
0.98%
Average volume (10 days)
257.64K
Average volume (90 days)
Price summary
52-Week low
37.55
52-Week high
64.98
52-Week change
9.05%
Beta
1.28
50-Day moving average
49.82
200-Day moving average
47.07
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-13.32%
Return on equity
-16.80%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-108,452,872.00
Net income to common (ttm)
-80,768,080.00
Diluted EPS (ttm)
-1.18
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
493.92M
Total cash per share (mrq)
7.83
Total debt (mrq)
3.38M
Total Debt/Equity (mrq)
0.68
Current ratio (mrq)
2.55K%
Book value per share (mrq)
7.74
Cash flow
Cash flow statement
-80,457,912.00
Levered free cash flow (LFCF)
-67,301,544.00